Inventor · disambiguated record
Tyler E. Jacks
Also filed as: JACKS TYLER · JACKS TYLER E
10 granted patents·12 pending applications·69 citations·filing 2002–2024
86Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY13BROAD INST INC3UNIV NEW YORK2AVEO PHARMACEUTICALS INC1JACKS TYLER1
Top patents by PatentIndex Score
22 records- 0197US10941395B2Method for gene editingMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Mar 9, 2021·33 cites·28 claims
- 0296US10047355B2Delivery systems and kits for gene editingMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Aug 14, 2018·21 cites·41 claims
- 0380US10548959B2Compositions and methods for modified dendrimer nanoparticle deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Feb 4, 2020·3 cites·26 claims
- 0475US12163124B2Method for gene editingMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Dec 10, 2024·0 cites·20 claims
- 0573US9567642B2Methods and products related to targeted cancer therapyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Feb 14, 2017·4 cites·9 claims
- 0668US2020155660A1Compositions and methods for modified dendrimer nanoparticle deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 0767US12419940B2Compositions and methods for modified dendrimer nanoparticle deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Sep 23, 2025·0 cites·23 claims
- 0867US7514207B2Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatmentMASSACHUSETTS INST TECHNOLOGY·Filed 2002·Granted Apr 7, 2009·7 cites·18 claims
- 0965US2024261245A1Methods of treating cancers having a deregulated nrf2/keap1 pathwayUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 1062US2024401150A1Pancreatic ductal adenocarcinoma signatures and uses thereofBROAD INST INC·Filed 2024·Application pending·0 cites
- 1155US11739156B2Methods and compositions for overcoming immunosuppressionBROAD INST INC·Filed 2020·Granted Aug 29, 2023·0 cites·8 claims
- 1253US2010008901A1Methods for the treatment and prevention of cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2009·Application pending·0 cites
- 1351US7622630B2Chimeric cancer modelsAVEO PHARMACEUTICALS INC·Filed 2004·Granted Nov 24, 2009·1 cites·6 claims
- 1450US2024043934A1Pancreatic ductal adenocarcinoma signatures and uses thereofBROAD INST INC·Filed 2021·Application pending·0 cites
- 1550US2021361603A1Methods of treating cancers having a deregulated nrf2/keap1 pathwayUNIV NEW YORK·Filed 2018·Application pending·0 cites
- 1645US2019365719A1Combination treatments of hsp90 inhibitors for enhancing tumor immunogenicity and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 1744US2010298329A1Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancersMASSACHUSETTE INST OF TECHNOLOGY·Filed 2008·Application pending·0 cites
- 1842US11331269B2Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatmentMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted May 17, 2022·0 cites·28 claims
- 1939US2007025914A1Bronchioalveolar stem cells and uses thereofJACKS TYLER·Filed 2006·Application pending·0 cites
- 2039US2005026878A1Steroid modulators in the treatment of peripheral nerve sheath tumorsFiled 2003·Application pending·0 cites
- 2137US2017015994A1Methods for in vivo genome editingMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Application pending·0 cites
- 2234US2015150892A1Methods and products related to lung cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →